Chuang Jing-Yuan, Kuo Hsiao-Hui, Wang Pei-Han, Su Chih-Jou, Yih Ling-Huei
Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan.
Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, 115, Taiwan.
Cell Div. 2024 Jun 24;19(1):22. doi: 10.1186/s13008-024-00126-w.
Nitrogen permease regulator-like 2 (NPRL2/TUSC4) is known to exert both tumor-suppressing and oncogenic effects in different types of cancers, suggesting that its actions are context dependent. Here, we delineated the molecular and functional effects of NPRL2 in malignantly transformed bronchial epithelial cells. To do so, we depleted NPRL2 in oncogenic HRas-transduced and malignantly transformed human bronchial epithelial (BEAS2B), Ras-AI-T2 cells. Intriguingly, depletion of NPRL2 in these cells induced activation of mTORC1 downstream signaling, inhibited autophagy, and impaired Ras-AI-T2 cell proliferation both in vitro and in vivo. These results suggest that NPRL2 is required for oncogenic HRas-induced cell transformation. Depletion of NPRL2 increased levels of the DNA damage marker γH2AX, the cell cycle inhibitors p21 and p27, and the apoptosis marker cleaved-PARP. These NPRL2-depleted cells first accumulated at G1 and G2, and later exhibited signs of mitotic catastrophe, which implied that NPRL2 depletion may be detrimental to oncogenic HRas-transformed cells. Additionally, NPRL2 depletion reduced heat shock factor 1/heat shock element- and NRF2/antioxidant response element-directed luciferase reporter activities in Ras-AI-T2 cells, indicating that NPRL2 depletion led to the suppression of two key cytoprotective processes in oncogenic HRas-transformed cells. Overall, our data suggest that oncogenic HRas-transduced and malignantly transformed cells may depend on NPRL2 for survival and proliferation, and depletion of NPRL2 also induces a stressed state in these cells.
已知氮通透酶调节因子样2(NPRL2/TUSC4)在不同类型的癌症中发挥肿瘤抑制和致癌作用,这表明其作用取决于具体环境。在此,我们阐述了NPRL2在恶性转化的支气管上皮细胞中的分子和功能效应。为此,我们在致癌性HRas转导的恶性转化人支气管上皮(BEAS2B)细胞Ras-AI-T2中敲低NPRL2。有趣的是,在这些细胞中敲低NPRL2会诱导mTORC1下游信号激活,抑制自噬,并在体外和体内损害Ras-AI-T2细胞增殖。这些结果表明,致癌性HRas诱导的细胞转化需要NPRL2。敲低NPRL2会增加DNA损伤标志物γH2AX、细胞周期抑制剂p21和p27以及凋亡标志物裂解的PARP的水平。这些NPRL2敲低的细胞首先在G1期和G2期积累,随后出现有丝分裂灾难的迹象,这意味着敲低NPRL2可能对致癌性HRas转化的细胞有害。此外,敲低NPRL2会降低Ras-AI-T2细胞中热休克因子1/热休克元件和NRF2/抗氧化反应元件指导的荧光素酶报告基因活性,表明敲低NPRL2会导致致癌性HRas转化细胞中两个关键的细胞保护过程受到抑制。总体而言,我们的数据表明,致癌性HRas转导的恶性转化细胞可能依赖NPRL2来生存和增殖,敲低NPRL2也会在这些细胞中诱导应激状态。